• Home>
  • Stocks>
  • Ind-Swift Laboratories Ltd Share Price
Ind-Swift Laboratories Ltd share price logo

Ind-Swift Laboratories Ltd Share Price

(INDSWFTLAB)

₹93.585.24%

as on 03:29PM, 21 Feb 2025

bell
The current prices are delayed by 15 mins, login to check live prices.

Ind-Swift Laboratories Ltd Performance

  • Day's Low

    Day's High

    ₹88.2
    Day's Price Range
    ₹94.7
  • 52 Week's Low

    52 Week's High

    ₹85.09
    52-Week Price Range
    ₹186
1 Month Return-22.29 %
3 Month Return-13.43 %
1 Year Return-18.38 %
Previous Close₹88.92
Open₹93.06
Volume1.24L
Upper Circuit-
Lower Circuit-
Market Cap₹525.40Cr

Ind-Swift Laboratories Ltd Key Statistics

P/E Ratio

1.48

PEG Ratio

0.03

Market Cap

₹525.40 Cr

P/B Ratio

0.63

EPS

71.33

Dividend Yield

0

Sector

Pharmaceuticals

ROE

18.99

Key events for Ind-Swift Laboratories Ltd

  • NCLT Approves Meeting for Ind-Swift Amalgamation - 05 Jan, 2025

    The NCLT Chandigarh has directed Ind-Swift Ltd to convene meetings of equity shareholders and unsecured creditors to consider the proposed amalgamation with Ind Swift Laboratories Limited.

Insights on Ind-Swift Laboratories Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Retail Holding Up

    img

    Retail Investor have increased holdings from 56.41% to 56.60% in Dec 2024 quarter

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 42.00% of holdings in Dec 2024 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Divis Laboratories Ltd has given 63.8% return, outperforming this stock by 82.2%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Torrent Pharmaceuticals Ltd has given 133.2% return, outperforming this stock by 106.6%

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 4 quarters, 805.18 Cr → 22.48 Cr (in ₹), with an average decrease of 49.4% per quarter

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 1 month, INDSWFTLAB stock has moved down by -22.3%

  • imgNEGATIVE IMPACT

    FII Holding Down

    img

    Foreign Institutions have decreased holdings from 0.65% to 0.46% in Dec 2024 quarter

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 4 quarters, 352.64 Cr → 0.01 Cr (in ₹), with an average decrease of 84.6% per quarter

Ind-Swift Laboratories Ltd Financials

Value in ₹ crore
DetailsQ'4 23Q'1 24Q'2 24Q'3 24Q'4 24
Revenue₹287.51Cr (-)₹393.33Cr (↑36.81%)₹33.17Cr (↓91.57%)₹11.96Cr (↓63.94%)₹8.66Cr (↓27.59%)
Net Income₹19.53Cr (-)₹352.69Cr (↑1,705.89%)₹1.01Cr (↓99.71%)₹0.40Cr (↓60.40%)-₹0.01Cr (↓102.50%)
Net Profit Margin6.79% (-)89.67% (↑1,220.62%)3.04% (↓96.61%)3.34% (↑9.87%)-0.12% (↓103.59%)
Value in ₹ crore
Details2021202220232024
Total Assets₹1,817.20Cr (-)₹1,802.92Cr (↓0.79%)₹1,788.27Cr (↓0.81%)₹1,104.77Cr (↓38.22%)
Total Liabilities₹1,178.50Cr (-)₹1,170.36Cr (↓0.69%)₹1,112.92Cr (↓4.91%)₹182.52Cr (↓83.60%)
Value in ₹ crore
Details20202021202220232024
Operating Cash Flow₹123.16Cr (-)₹135.03Cr (↑9.64%)₹136.26Cr (↑0.91%)₹182.67Cr (↑34.06%)-₹179.77Cr (↓198.41%)

Ind-Swift Laboratories Ltd Shareholding Pattern

InvestorsHoldings %FY Quarter3M change
Promoter Holdings
42%
0.00
Foreign Institutions
0.46%
-29.80
Mutual Funds
0%
0.00
Retail Investors
56.6%
0.34
Others
0.94%
0.00

Ind-Swift Laboratories Ltd Key Indicators

Details20202021202220232024
Return On Assets %-1.09-0.17-0.122.6638.1
Details20202021202220232024
Book Value Per Share (₹)69.4965.6767.6383.36157.64
Details20202021202220232024
Earning Per Share (₹)-3.54-0.53-0.36871.33
Details20232024
Return On Equity %11.5718.99

Ind-Swift Laboratories Ltd Valuation

Ind-Swift Laboratories Ltd in the last 5 years

  • Overview

  • Trends

Lowest (-1795.00x)

December 8, 2022

Today (1.48x)

February 20, 2025

Industry (51.76x)

February 20, 2025

Highest (64.97x)

July 19, 2021

LowHigh

Ind-Swift Laboratories Ltd Earnings and Dividends

  • Ind-Swift Laboratories Ltd Earnings Results

    Ind-Swift Laboratories Ltd’s net profit fell -99.95% since last year same period to ₹0.01Cr in the Q3 2024-2025. On a quarterly growth basis, Ind-Swift Laboratories Ltd has generated -97.56% fall in its net profits since last 3-months.

    Read More about Earnings Results

Ind-Swift Laboratories Ltd Technicals Summary

Bearish

Neutral

Bullish

Bearish

Ind-Swift Laboratories Ltd is currently in a Bearish trading position according to technical analysis indicators.

Ind-Swift Laboratories Ltd Peer Comparison

Company
Analyst ViewMarket Cap5 Year CAGRDebt to Asset RatioNet ProfitYearly Revenue
NA₹525.40 Cr65.5%0.51₹421 Cr₹1,280 Cr
NA₹686.80 Cr124.79%0.91₹55 Cr₹575 Cr
NA₹103.20 Cr31.27%0.55NANA
NA₹671.21 Cr28.67%0.69₹5 Cr₹1,684 Cr
NA₹98.19 Cr37.72%0.73NANA

About Ind-Swift Laboratories Ltd

IndSwift Laboratories Ltd is an Indian based company that manufactures and sell Active Pharmaceutical Ingredients (API). Established in 1995, the company has grown to encompass 25 products, the most significant being Clarithromycin Macrolide antibiotic, Atorvastatin anticholestrol, Fexofenadine antihistamine, Clopidogrel anticholestrol, Nitazoxanide antidiarrheal, Pioglitazone antidiabetic, Letrozole and Anastrozole anticancer, Venlafaxine antidepressants, and Quetipine and Aripirazole antipsychotic. IndSwift Laboratories Ltd has built a strong presence in 40 plus countries, have a subsidiary in the USA, and set up a state of the art R&D Centre with a USD 5 million investment. Additionally, the production capacity has been increased to 418.18 TPA and its product portfolio continues to expand with compounds like Dutasteride, Cinacalcet, Duloxetine, Mecloxamine citrate, Atomoxetine, Exemestane, and more. In order to explore new opportunities in pharma, the company has entered joint ventures with Wellgen Medicare LLP and Mr. Anshul Jain, and Mr. Ramesh Mehta. As of now, the company has 3 subsidiaries - IndSwift Laboratories Inc in the US, Fortune India Constructions Limited in India, and Halcyon Life Sciences Pvt Ltd in India.

Share Price: ₹93.58 per share as on 21 Feb, 2025 03:29 PM
Market Capitalisation: ₹525.40Cr as of today
Revenue: ₹8.66Cr as on December 2024 (Q4 24)
Net Profit: ₹0.01Cr as on December 2024 (Q4 24)
Listing date: 02 Jul, 1997
Chairperson Name: N R Munjal
OrganisationInd-Swift Laboratories Ltd
HeadquartersChandigarh
IndustryPharmaceuticals
E-voting on sharesClick here to vote

FAQs on Ind-Swift Laboratories Ltd

What is Ind-Swift Laboratories Ltd price today?

Ind-Swift Laboratories Ltd share price today stands at ₹93.58, Open: ₹93.06, Previous Close: ₹88.92, High: ₹94.7, Low: ₹88.2, 52 Week High: ₹186, 52 Week Low: ₹85.09.

How to Buy Ind-Swift Laboratories Ltd Share in India?

  • Get a PAN card
  • Open a Demat account
  • Open a Trading account
  • Link your Demat account to your Trading account
  • Fund your Trading account
  • Place an order to buy Ind-Swift Laboratories Ltd shares

Is Ind-Swift Laboratories Ltd listed on NSE?

Ind-Swift Laboratories Ltd is listed on NSE

Is Ind-Swift Laboratories Ltd listed on BSE?

Ind-Swift Laboratories Ltd is listed on BSE

What are today's High and Low prices of Ind-Swift Laboratories Ltd?

  • Today's highest price of Ind-Swift Laboratories Ltd is ₹94.7.
  • Today's lowest price of Ind-Swift Laboratories Ltd is ₹88.2.

What are today's traded volumes of Ind-Swift Laboratories Ltd?

Today's traded volume of Ind-Swift Laboratories Ltd(INDSWFTLAB) is 1.24L.

What is today's market capitalisation of Ind-Swift Laboratories Ltd?

Today's market capitalisation of Ind-Swift Laboratories Ltd(INDSWFTLAB) is ₹525.4Cr.

What is the 52 Week High and Low Range of Ind-Swift Laboratories Ltd?

Ind-Swift Laboratories Ltd (INDSWFTLAB)
Price
52 Week High
₹186
52 Week Low
₹85.09

How much percentage Ind-Swift Laboratories Ltd is down from its 52 Week High?

Ind-Swift Laboratories Ltd (INDSWFTLAB) share price is ₹93.58. It is down -49.69% from its 52 Week High price of ₹186

How much percentage Ind-Swift Laboratories Ltd is up from its 52 Week low?

Ind-Swift Laboratories Ltd (INDSWFTLAB) share price is ₹93.58. It is up 9.98% from its 52 Week Low price of ₹85.09

What are the historical returns of Ind-Swift Laboratories Ltd?

Ind-Swift Laboratories Ltd (INDSWFTLAB)
Returns
1 Day Returns
4.66%
1 Month Returns
-22.29%
3 Month Returns
-13.43%
1 Year Returns
-18.38%

What is the PE ratio of Ind-Swift Laboratories Ltd today?

PE Ratio of Ind-Swift Laboratories Ltd is 1.48

PE ratio = Ind-Swift Laboratories Ltd Market price per share / Ind-Swift Laboratories Ltd Earnings per share